Biomarkers Europe 2024

30 September - 01 October 2024 | Basel, Switzerland

Thank you to all attendees, speakers, and sponsors of Biomarkers Europe 2024 for making this event a success.

You may be interested in Biomarkers & Precision Medicine 2025.

Event Page - Hero Banner 3
Overview Biomarkers Precision Oncology
+co-located event:
Spatial Biology

Formed of the 3rd Annual Biomarkers Europe and 2nd Annual Precision Oncology Europe Congresses, Biomarkers Europe 2024 is focused on driving the advancement of biomarkers within the fields of oncology and immunotherapy.

The co-located events provide a specialized platform to explore the most innovative technologies and approaches for biomarker validation & Identification, biomarker analysis, applications in precision oncology & patient treatment in clinical trials.

With over 50 presentations, these two-day congresses provide multiple opportunities for engaging scientific insights, valuable networking, and interactive panel & workshop discussions.

Over 500 leading industry experts and clinicians will engage on biomarker end points, personalised patient treatment and companion diagnostics development including early detection technologies & liquid biopsies.

3rd Annual Biomarkers Europe Congress

Addressing challenges in biomarker analysis to accelerate timelines in drug development including the role of safety and efficacy biomarkers . Discover novel approaches into optimising biomarker analysis through effective assay development, as well as utilising the latest multiplexed tools impacting biomarker research and validation.

  • Acquire knowledge about how biomarker approaches are utilized in drug discovery and translational sciences for oncology and immuno-related therapies.
  • Explore how companies accelerate timelines and reduce risk in drug development. Presentations consider the latest applications of Biomarker Analysis – Multiplex Technology Application & Translational Research in oncology & Immunological disorders
  • Gain insights into emerging bioanalysis approaches, assay development, and what can be translated in the clinic

Agenda at a Glance


3rd Annual Biomarkers Europe Congress

  • Day One | Track 1: Biomarkers For Diagnostic Development & Clinical Development
  • Day One | Track 2: Identification, Qualification & Validation of Biomarkers in Translational Studies
  • Day Two: Data-Driven Approaches for Biomarker Analysis in Drug Development

2nd Annual Precision Oncology Europe Congress

Bringing together experts In Oncology And Cancer Care, Clinical Research, and Drug Development To Explore application in diagnosis, stratification & prognosis in oncology, and advancing personalized treatment to improve patient outcomes.

  • Showcasing the latest technologies and clinical studies in multi-cancer early detection and minimal residual disease testing
  • Learn about molecular characterization of tumour for targeted therapy selection
  • Explore biomarker and companion diagnostics discovery, and development
  • Gain insights from genomics-enabled clinical trials for tailored cancer drug development

Agenda at a Glance


2nd Annual Precision Oncology Europe Congress

  • Day One: Multi-Cancer Early Detection Techniques & Companion Diagnostics for Precision Oncology
  • Day Two: Digital Technologies For Advancing Biomarkers In The Clinic & Personalized Patient Treatments 

3rd Annual Spatial Biology Europe Congress

Attendees of Biomarkers Europe 2024 also have access to Spatial Biology Europe 2024

Explore Spatial Biology Europe 2024: Unlocking Future Insights in Spatial Biology Research

Join leaders, experts and researchers at the 3rd Annual Spatial Biology Europe Congress, connecting global academic & research organisations as well as pharma representatives for high-level discussions on the latest innovations in spatial research & technologies. Forward looking visionary leaders will discuss the current state of the industry, market trends and future growth areas aiding the application of spatial technologies in the clinic.

  • Take a deep dive into image analysis, AI-powered imaging, and utilising digital pathology for spatial biology. Key opinion leaders will be providing insights into computational image analysis, multiplexed digital pathology, and the utilisation of AI & machine learning within spatial transcriptomic studies 
  • Discuss the latest innovations in spatial bioinformatics and data analytics. Presentations will delve into the use of spatial data in biology, modelling cell-cell communications, and computational algorithms for spatial analysis. A focused workshop will investigate how to overcome the challenges of spatial data integration
  • Gain comprehensive insights into novel application areas for spatial biology. This event will cover the applications of spatial data across a variety of therapeutic areas including neuroimmunology, oncology, cardiology and more. Discussions will also involve strategies for making spatially targeted therapeutics more precise
  • Hear from leading innovators utilizing spatial biology in pharma. See how leading pharmaceutical companies are beginning to integrate spatial biology into R&D to accelerate timelines and move towards the clinic

Agenda at a Glance


  • Day One | Track 1: Spatial Multi Omics Techniques & Approaches
  • Day One | Track 2: Image Analysis, AI-Powered Imaging & Digital Pathology for Spatial Biology
  • Day Two | Track 1: Spatial Bioinformatics, Data Analytics and Interpretation
  • Day Two | Track 2: Applications of Spatial Research & Technologies in Biology

What to Expect

500

leading pharma, biotech, & academic delegates

12
hours of presentations, discussions & interactive content
9
hours of networking breaks, including speed networking & refreshments
100
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 50 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

NEW FOR 2024!

Executive-Level Panel Discussions

These closed door sessions will include insights from key opinion leaders spearheading innovation in Biomarkers & Precision Oncology. Places are limited — secure your spot now by selecting a session during registration.

Closed Door Panel Discussion: 
Challenges in Translating Exploratory Biomarkers into the Clinic

Moderated by:
GUNTHER JANSEN, Senior Director, Precision Medicine & Data Science, Novartis

Closed Door Workshop: 
Advancements in Liquid Biopsy 
Technologies for Precision Oncology

Presented by:
NOLWEN GUIGAL-STEPHAN, Head of 
Clinical Biomarkers, Servier

ED SCHUURING, Clinical Scientist in 
Molecular Pathology, University Medical Centre Groningen

Closed Door Panel Discussion: How to Bridge the Gap Between the Bench & Bedside: Applications of Precision Medicine in a
Healthcare Setting

Stay tuned for Moderator details

Companies Represented Include

Meet Our Expert Speakers

Biomarkers Europe 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Below are some of our featured speakers:

Amanda Heslegrave
Senior Research Fellow,
University College London
Brian Lockhart
Head of CDx,
Servier
Cornelia Wilson
Reader and Academic Laboratory Director,
Canterbury Christ Church University
Dirk Kemming
Medical Director Diagnostics Europe,
Daiichi Sankyo Europe
Ed Schuuring
Clinical Scientist in Molecular Pathology,
University Medical Center Groningen
Gunther Jansen
Head of Multimodal Data & Analytics,
Novartis
Joanna Janus
Research Programme Manager,
CRUK
Marine Garrido
Global Translational Leader,
Bayer
Olga Nissan
C EO,
Protica Bio
Philip Beer
Chief Scientific Officer,
Step Pharma
Shashank Saran
Associate Director,
AstraZeneca
Aitana Sogorb-Esteve
Senior Research Fellow,
University College London
Alain van Gool
Professor Personalized Healthcare,
Radboud University Medical Center
Aliya Sarmanova
Clinical Development Lead Oncology & Genetics,
Roche
Andrew Janowczyk
Assistant Professor,
Emory University
Bernhard Reis
Expert Biomarker & Translational Medicine Leader; Group Head Biomarker Strategy,
F. Hoffman-La Roche Ltd.
Christian Ruiz
Chief Scientific Officer,
University of Basel
Christophe Le Tourneau
Medical Oncologist,
Institut Curie
Dana Mustafa
Assistant Professor & Group Leader,
Erasmus MC
Daniel Keitley
Research Scientist,
Novo Nordisk
Dylan Powell
Assistant Professor in Public Health & Innovation,
Stirling University
Guillaume Desachy
Head Of Biometrics,
Pierre Fabre
Jacques Colinge
Professor,
University of Montpellier, France
Jan Christoph Brase
Global Translational Science Leader,
Bayer
Jehad Charo
Biomarker & Experimental Medicine Leader,
Hoffmann La Roche Ltd
Jun Frederiksen
Director,
Novo Nordisk
Malleswari Challagundla
Senior Scientist II,
AbbVie Deutschland GmbH & Co. KG
Maximilian Breitner
Lab Head Clinical Bioanalytics,
Sandoz
Mohammad Arastoo
Research Fellow,
University of Aberdeen/ TauRx Pharmaceuticals
Nolwen Guigal-Stephan
Head of Clinical Biomaker Development,
Servier Monde
Sina Nassiri
Principal Bioinformatics Scientists & Team Lead,
Roche
Thomas Jensen
CEO,
Allarity Therapeutics
Vinko Tosevski
Senior Director Translational Research,
Immunos Therapeutics

Interested in Sponsoring?

Our extensive and engaged community extends across large, mid-size and emerging companies within the pharma and biotech space, with a dedicated audience spanning a range of specialisms. Whether you have content to share, are looking for ways to enhance your brand visibility or would like to increase engagement with prospective customers, Oxford Global can offer valuable access to your target demographic through our range of event & content services.

Latest Resources

Imaging Starts Using Brand New Radiotracer from Nuclidium

The radiotracer is the first part of Nuclidium’s proposed ‘theranostic pipeline’ which aims to diagnose, stage, and then treat prostate cancer.

GHR Foundation Commits $15m to C2N Diagnostics for Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease

GHR’s total investment in C2N has now broken $50 million since 2020.

Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality

The study from the Federal University of Paraíba, Brazil analyses a series of haematological, biochemical, and inflammatory factors all contribute to the mortality of COVID-19 patients in the ICU.

Group Identify Prognostic Biomarker for SCLC and Treatment Using Chemotherapy

SCLC patients that express the gene PCDHB4 have a higher likelihood of developing a resistance to chemotherapy.

Proteomic Analysis of Serum Extracellular Vesicles Reveals Potential Biomarkers for Neuroblastoma

The proteomic analysis of extracellular vesicles is shaping up to be a promising biomarker discovery technique for diseases like neuroblastoma.

Blood Biomarkers Signal Increased Risk of Alzheimer's & MND After Multiple Rugby Concussions

Results that show rugby players that have sustained multiple concussions present with markers of neurodegenerative disease development.

Plan Your Visit

Congress Center Basel
MCH Swiss Exhibition (Basel) Ltd. Messeplatz 21, CH-4058 Basel

By Rail

Basel is an international rail hub with direct ICE, IC and EC connections to Germany, Austria, Italy, France and the Benelux countries. Messe Basel can be reached in five to ten minutes from the three railway stations in Basel: SBB (Switzerland), SNCF (France) (Frankreich) and DB (Badischer Bahnhof, Germany)

By Tram

From the SBB/SNCF railway station, it’s a ten-minute journey on the No. 1 or 2 Tram to the “Messeplatz/Exhibition Square” stop where Messe Basel and the Congress Center are located. From Badischer Bahnhof railway station, “Messeplatz/Exhibition Square” is the second stop on the No. 2 or 6 tram.

By Air

EuroAirport Basel-Mulhouse-Freiburg is 15 minutes by car from Messe Basel. Basel municipal transport’s No. 50 bus additionally provides a straightforward connection from the airport to the SBB/SNCF railway station. From there, tram No. 1 or 2 will take you directly to Messeplatz/Exhibition Square. From Zurich Airport a direct rail connection will bring you to the SBB/SNCF railway station in Basel in less than an hour. For further information including a map and full directions, please visit: https://www.messe-basel.com/en/about-us/getting-to-messe-basel/

By Car

Basel is located at the point where the Swiss, German and French motorway networks all meet. The exhibition and congress site has its own direct link to the A2 motorway. The “Messe” exit will take you straight to the Messe Basel car park with its 1,200 parking spaces.

Our rooms at the Basel Marriott Hotel are now sold out. However, you can still reserve directly with the hotel or explore nearby alternative options by clicking here.

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Biomarkers Europe 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch